ACTRN12611000287932已完成不适用
Cost-effectiveness of weight loss for type 2 diabetics: a randomised controlled trial of LapBand placement
Centre for Obesity Research & Education0 个研究点目标入组 200 人开始时间: 2011年3月18日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 60 Years（—）
- 性别
- All
入选标准
- •1. obese (BMI >30)
- •2. undergone bariatric surgery
排除标准
- •1. previous stomach surgery
- •2. aged > 60 years
研究者
相似试验
招募中
1 期
Effect of Fucoidan on glucose control and markers of cardiometabolic health after chronic dosingHyperlipidaemiaHypercholesterolaemiaInsulin Resistance/sensitivityGlucose toleranceMetabolic and Endocrine - DiabetesMetabolic and Endocrine - Metabolic disordersCardiovascular - Normal development and function of the cardiovascular systemDiabetesObesityACTRN12614000495628niversity of Tasmania.80
已完成
3 期
A Study to Evaluate the Effect of Vildagliptin on the Maximum Insulin Secretion in Patients With Type 2 DiabetesDiabetes Mellitus, Type 2NCT00351585Novartis39
终止
2 期
A Study To Assess GW677954 Used In Combination With Insulin In Subjects Who Have Type 2 Diabetes MellitusType 2 Diabetes MellitusDiabetes Mellitus, Type 2NCT00437164GlaxoSmithKline1
进行中（未招募）
1 期
A trial to evaluate the efficacy and safety of different doses of LEO 138559 in adults with moderate-to-severe atopic dermatitis.Atopic DermatitisCTIS2022-500777-14-00eo Pharma A/S250
进行中（未招募）
不适用
A phase 2b, randomised, double-blind, placebo-controlled, multi-centre, dose-finding study to evaluate the efficacy, safety, pharmacokinetics, and pharmacodynamics of BG9924 when given in combination with methotrexate to subjects with active Rheumatoid Arthritis who have had an inadequate response to anti-TNF therapyRheumatoid arthritis (RA)MedDRA version: 9.1Level: PTClassification code 10039073Term: Rheumatoid arthritisEUCTR2006-005467-26-BEBiogen Idec Ltd120